tiprankstipranks
Ibio Inc (DE:0JVN)
FRANKFURT:0JVN

Ibio (0JVN) Stock News & Sentiment

0 Followers
iBio Reports Preliminary Unaudited Fiscal Year 2022 Financial Results and Provides Corporate Update
PremiumPress Releases
iBio Reports Preliminary Unaudited Fiscal Year 2022 Financial Results and Provides Corporate Update
2y ago
BRYAN, Texas and SAN DIEGO, Sept. 27, 2022 (GLOBE NEWSWIRE) — iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable FastPharming® Manufacturing System, today announces preliminary unaudited financial results for the fiscal year ended June 30, 2022, and provides a ...Read more
iBio Acquires RubrYc Therapeutics’ AI Drug Discovery Platform and Pipeline
PremiumPress Releases
iBio Acquires RubrYc Therapeutics’ AI Drug Discovery Platform and Pipeline
2y ago

0JVN News on the Web

News Score - Last 7 Days

Negative
DE:0JVN
Sector Average
Media Buzz
This Week2 articles
Weekly Average2.5 articles
News Sentiment
This Week0%
Sector Average60%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:0JVN’s Media Buzz Sentiment?
2 articles about DE:0JVN were published this week. In an average week, 2.5 articles are published.
    What is DE:0JVN’s weekly average amount of articles?
    In an average week, 2.5 articles about DE:0JVN are published.
      What is DE:0JVN’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      OFIXOrthofix
      NVIVInvivo Therapeutics Holdings
      KROSKeros Therapeutics
      SPNESeaSpine Holdings
      AMGNAmgen
      Showing the stocks with the most bullish news sentiment over the past week
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis